Trending News

SharpLink Gaming (Nasdaq: SBET) announced it will ring the Nasdaq Stock Market closing bell on July 7, 2025, celebrating its position as the world's largest publicly traded company to adopt Ethereum (ETH) as its primary treasury reserve asset.

The milestone event highlights SharpLink's strategic embrace of decentralized finance (DeFi), with Joseph Lubin, Chairman of SharpLink and Co-Founder of Ethereum, emphasizing the company's view of ETH as a resilient store of value. CEO Rob Phythian positioned this move as demonstrating how digital assets can align with public market requirements and corporate governance.

Webull (NASDAQ:BULL) has secured a $1 billion standby equity purchase agreement with Yorkville Advisors' investment fund YA II PN, Ltd. The three-year agreement allows Webull to issue Class A ordinary shares at its discretion, with shares priced at a 2.5% discount to the Market Price during each one-day pricing period.

The company plans to strategically utilize this capital for growth initiatives, including product expansion, new asset classes, and geographic expansion. Webull's management views this financing option as crucial for pursuing opportunities in next-generation technologies like stable coins and real-world asset tokenization.

OS Therapies (NYSE-A: OSTX) has achieved a significant milestone as the FDA granted an End of Phase 2 Meeting for its OST-HER2 program, targeting the prevention of recurrent, fully resected, pulmonary metastatic osteosarcoma. The meeting is scheduled for Q3 2025.

The company plans to pursue a Rolling Review process for its Biologics Licensing Application (BLA), potentially expediting the approval timeline. OST-HER2 has secured multiple FDA designations including Orphan Disease, Fast Track, and Rare Pediatric Disease Designation. If granted Accelerated Approval before September 30, 2026, OSTX could receive a Priority Review Voucher, with recent vouchers valued at $160 million.

OST-HER2 is an immunotherapy using HER2-bioengineered Listeria monocytogenes to target HER2-expressing cancer cells, with ongoing development in both human and canine applications.

UiPath (NYSE: PATH) has announced a four-year partnership with Romanian Olympic swimming champion David Popovici as its Global Ambassador. The 20-year-old freestyle swimming specialist, who won gold in the 200m and bronze in the 100m freestyle at the 2024 Paris Olympics, will support UiPath's global events, including the upcoming UiPath FUSION event in Las Vegas.

Popovici's achievements include becoming the first male swimmer in 49 years to win both 100m and 200m freestyle at the 2022 World Championships, and setting world records at the 2022 European Championships. The partnership will support his preparation through major competitions, including the 2028 Los Angeles Olympics.

REE Automotive (NASDAQ:REE), an automotive technology company specializing in software-defined vehicle technology solutions, has received a notification from Nasdaq regarding non-compliance with the minimum bid price requirement. The company's shares have traded below $1.00 for 30 consecutive business days from May 15, 2025, through June 27, 2025.

REE has been granted a 180-day compliance period until December 29, 2025, during which it must maintain a closing bid price of at least $1.00 for a minimum of ten consecutive business days. If unsuccessful, the company may be eligible for an additional 180-day period, provided it meets certain listing requirements. The notification has no immediate impact on REE's Nasdaq listing or trading status.

La Rosa Holdings Corp. (NASDAQ: LRHC), a real estate and PropTech company, has achieved two significant milestones in its growth trajectory. The company has surpassed 3,000 real estate agents across its network and reported preliminary unaudited revenue of $38.4 million for H1 2025, marking a 19.4% year-over-year growth.

CEO Joe La Rosa attributes this success to the company's platform strength, culture, and growing trust from real estate professionals. The company's strategy focuses on building high-performing offices, advancing agent success, and expanding both nationally and internationally. La Rosa's flexible brokerage model offers competitive compensation, including revenue share programs, a 100% commission option with low fees, and additional income opportunities through ancillary services and integrated technology solutions.

INOVIO Pharmaceuticals (NASDAQ: INO), a biotechnology company specializing in DNA medicines, has announced the pricing of a $25 million public offering. The offering consists of 14,285,715 shares of common stock along with Series A and Series B warrants, all priced at $1.75 per share.

The warrants allow holders to purchase up to an additional 14,285,715 shares each at an exercise price of $1.75. The underwriters, led by Piper Sandler & Co., have a 30-day option to purchase up to 2,142,857 additional shares and corresponding warrants. The offering is expected to close around July 7, 2025.

Alibaba Group (NYSE: BABA) has announced plans to issue approximately HK$12 billion of Zero Coupon Exchangeable Bonds due 2032, linked to Alibaba Health Information Technology Limited shares. The bonds will be offered privately to non-U.S. persons in offshore transactions outside the United States.

The bonds will be unsecured and unsubordinated, maturing on July 9, 2032, with holders having the option to exchange bonds for Alibaba Health shares, cash, or a combination of both. Alibaba Group currently holds approximately 64% equity interest in Alibaba Health and expects it to remain a consolidated subsidiary.

The proceeds will be used for general corporate purposes, including investments in cloud infrastructure and international commerce businesses. The offering includes provisions for investor hedging transactions and a Delta Placement arrangement for AH shares.

Olo Inc. (NYSE:OLO), a leading restaurant technology provider, has announced a definitive agreement to be acquired by Thoma Bravo in an all-cash transaction valued at approximately $2.0 billion. Under the agreement, shareholders will receive $10.25 per share, representing a 65% premium over the unaffected share price of $6.20 as of April 30, 2025.

Founded in 2005, Olo provides digital ordering, payments, and guest engagement solutions to over 750 restaurant brands and 88,000 locations, processing millions of transactions daily through its open SaaS platform. Following the transaction's completion, expected by the end of 2025, Olo will become a private company while maintaining its brand and operations.